StevenJeffreyHagerDO

Clinical Trials

• Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients Start of enrollment: 2011 Apr 01

  Completed

  Phase 1

• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor Start of enrollment: 2012 Aug 07

  Completed

  Phase 3

• Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer Start of enrollment: 2013 Mar 25

  Completed

  Phase 2

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16

  Terminated

  Phase 3

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02

  Terminated

  Phase 3

• Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy Start of enrollment: 2013 Jun 01

  Completed

  Phase 1, Phase 2

• Observational Registry Study of Quality of Life When Treating BTcP With Abstral Start of enrollment: 2013 Oct 01

  Completed

• Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2

• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23

  Completed

  Phase 3

• Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09

  Recruiting

  Phase 1, Phase 2

  Roles: Contact

• Join now to see all